logo

Oxygenta Pharmaceutical Ltd. Financials

16:01 Jul 18

Oxygenta Pharmaceutical Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
105.60
-4.45 (-4.04%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Oxygenta Pharmaceutical Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
105.60
-4.45 (-4.04%)
16:01 Jul 18
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

8/100
Expensive Valuation

Technical

55/100
Technically Neutral

Strength

7

Weakness

3

Opportunity

1

Threats

0

-7.70 %

ROE %

-12.43 %

ROA %

0.00

EPS

-6.93

BVPS

0.00 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
52.03 60.52 30.99 39.64 109.3
Operating Expenses +
48.18 59.06 38.1 49.34 119.3
Raw Material
43.02 42.67 28.13 35.06 100.23
Increase Decrease in Cost
-6.39 4.55 -4.63 -1.53 -3.76
Other Manufacturing Expense
5.67 5.45 11.73 7.44 0
Employee Cost
4.21 4.6 1.24 5.99 6.9
Miscellaneous Expenses
1.67 1.79 1.63 2.38 15.93
Operating Profit
3.85 1.46 -7.11 -9.7 -10
Other Income
0.09 0 0.02 0.04 1.31
Depreciation
1.2 1.59 2.05 2.66 1.78
Interest
1.78 0.92 1.49 1.59 3.61
Profit before tax and exceptio..
0.95 -1.04 -10.64 -13.91 -14.08
Exceptional Items
2.19 0.55 -0.73 0.04 -0.27
PBT
3.14 -0.49 -11.37 -13.87 -14.35
Provision for Taxation
0.21 0.12 0.2 -10.39 -4.05
Net Profit
2.93 -0.61 -11.57 -3.48 -10.3
NET Profit after MI
0 0 0 0 0
EPS
2.87 -0.48 -8.15 -1.09 -2.86
Operating Profit Margin (%)
7.4 2.41 -22.94 -24.47 -9.15
Net Profit Margin (%)
5.63 -1.01 -37.33 -8.78 -9.42

Oxygenta Pharmaceutical Ltd. Shareholding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 51.10 51.10 53.30 33.70 29.70
FII 0.00 0.00 0.00 0.00 0.00
MF 0.00 0.00 0.00 0.00 0.00
Others 0.00 0.00 0.00 0.00 0.00
Shareholder Shares Holding %
Research 360 logo
Download Our App On: